Staphylococcus epidermidis from prosthetic joint infections induces lower IL-1β release from human neutrophils than isolates from normal flora

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Emeli MånssonIsak Demirel

Abstract

The aim of this study was to test the hypothesis that Staphylococcus epidermidis isolated from prosthetic joint infections (PJIs) differs from S. epidermidis isolated from normal flora in terms of its capacity to induce activation of caspase-1 and release of IL-1β in human neutrophils. The amount of active caspase-1 was determined over 6 h by detecting Ac-YVAD-AMC fluorescence in human neutrophils incubated with S. epidermidis isolates from PJIs (ST2) or normal flora. The amount of IL-1β was detected by ELISA in neutrophil supernatants after 6 h of incubation. Mean IL-1β release was lower after incubation with S. epidermidis from PJIs compared to isolates from normal flora, but no statistically significant difference was found in active caspase-1. Substantial inter-individual differences in both active caspase-1 and IL-1β were noted. These results suggest that evasion of innate immune response, measured as reduced capacity to induce release of IL-1β from human neutrophils, might be involved in the predominance of ST2 in S. epidermidis PJIs, but that other microbe-related factors are probably also important.

References

Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E SärndahlT Andersson
Jan 4, 2001·The New England Journal of Medicine·C von EiffG Peters
Jul 14, 2001·Scandinavian Journal of Infectious Diseases·A AugustinssonL Ohman
Oct 16, 2004·The New England Journal of Medicine·Werner ZimmerliPeter E Ochsner
Mar 3, 2010·PLoS Pathogens·Mihai G NeteaLeo A B Joosten
May 11, 2010·International Journal of Medical Microbiology : IJMM·Sonja M K SchoenfelderWilma Ziebuhr
Mar 30, 2011·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Nicholas M BernthalLloyd S Miller
Jan 4, 2012·European Journal of Immunology·Arun K MankanVeit Hornung
Jan 20, 2012·Nature·Till StrowigRichard Flavell
May 5, 2012·The Journal of Arthroplasty·Steven M KurtzJavad Parvizi
Jun 13, 2012·Antimicrobial Agents and Chemotherapy·Rodrigo E MendesDavid J Farrell
Jul 31, 2012·Clinics in Geriatric Medicine·C Allyson Jones, Sheri Pohar
Jan 3, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Berolla SahdoBo Söderquist
Apr 30, 2013·Journal of Leukocyte Biology·Tamar TakLeo Koenderman
Dec 20, 2013·The Journal of Bone and Joint Surgery. American Volume·Benjamin ZmistowskiJavad Parvizi
Jan 9, 2014·The Journal of Biological Chemistry·Martina BakeleDominik Hartl
Apr 4, 2014·Clinical Microbiology Reviews·Aaron J Tande, Robin Patel
Jan 23, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mausita KarmakarEric Pearlman
Apr 29, 2015·Seminars in Immunology·Sunny Shin, Igor E Brodsky
Jun 19, 2015·Nature Immunology·Mihai G NeteaLuke A J O'Neill
Sep 4, 2015·The Journal of Bone and Joint Surgery. American Volume·Hilal Maradit KremersDaniel J Berry
May 20, 2016·Clinical & Translational Immunology·Md Nahidul IslamRhodri Ceredig
May 12, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Kartheyaene JayaprakashTorbjörn Bengtsson
Aug 22, 2017·Frontiers in Microbiology·Marina Sabaté BrescóT Fintan Moriarty

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

© 2022 Meta ULC. All rights reserved